Quest Diagnostics Acquires Pack Health

Quest Diagnostics Acquires Haystack Oncology

April 27, 2023

Healthcare Services

Quest Diagnostics has agreed to acquire Haystack Oncology in an all-cash transaction valued at $300 million at closing plus up to $150 million in potential milestones. The acquisition adds Haystack's sensitive ctDNA-based minimal residual disease (MRD) liquid biopsy technology to Quest's oncology, genomics and pathology capabilities to expand clinical lab services for MRD testing beginning in 2024.

Quest Diagnostics Acquires Labtech Diagnostics

December 14, 2021

Healthcare Services

Quest Diagnostics has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory based in Anderson, South Carolina. The acquisition brings Labtech into Quest’s national laboratory network — Quest’s first full-service laboratory in South Carolina — and expands Quest’s diagnostic capabilities and presence across the Southeast.

Quest Diagnostics Acquires LifeLabs from OMERS for CAN$1.35B

July 8, 2024

Healthcare Services

Quest Diagnostics has agreed to acquire LifeLabs from Canadian pension fund OMERS for approximately CAN$1.35 billion (approximately USD $985 million), including net debt. LifeLabs will retain its brand, Toronto-area headquarters, and management, and Quest expects the acquisition to expand its diagnostic footprint in Canada while enhancing service offerings and data security.

Packaging Compliance Labs Acquires Quest Engineering Solutions

May 13, 2025

Healthcare Services

Packaging Compliance Labs (PCL), a PE-backed provider of sterile packaging and testing services, has acquired Quest Engineering Solutions, an ISO 17025-accredited test lab based in Billerica, Massachusetts. The add-on expands PCL's East Coast footprint and broadens its testing capabilities for medical device and life sciences customers; PCL is backed by SV Health Investors.

MultiPlan Corporation Acquires Discovery Health Partners

January 21, 2021

Healthcare Services

MultiPlan Corporation agreed to acquire Discovery Health Partners for about $155 million plus transaction costs. The acquisition expands MultiPlan’s payment integrity capabilities by adding Discovery’s revenue integrity service line, deepening its penetration in the government market and extending its suite of analytics-driven cost-management solutions for health payors.

EmeritusDX Acquires Sprint Diagnostics

July 2, 2024

Healthcare Services

EmeritusDX, a cancer diagnostics and information company, has entered a definitive agreement to acquire Sprint Diagnostics to expand its Pharma Services Division. The acquisition adds advanced diagnostic capabilities and laboratory production capacity to EmeritusDX's CLIA-certified operations, supporting growth in pharmaceutical and clinical trial services.